90 related articles for article (PubMed ID: 30796053)
1. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
[TBL] [Abstract][Full Text] [Related]
2. The chromogranin A
Rocca C; Grande F; Granieri MC; Colombo B; De Bartolo A; Giordano F; Rago V; Amodio N; Tota B; Cerra MC; Rizzuti B; Corti A; Angelone T; Pasqua T
Acta Physiol (Oxf); 2021 Apr; 231(4):e13570. PubMed ID: 33073482
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumor growth by circulating full-length chromogranin A.
Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
Curnis F; Colombo B; Corti A
Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
[TBL] [Abstract][Full Text] [Related]
5. A new chromogranin A-dependent angiogenic switch activated by thrombin.
Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.
Bianco M; Gasparri AM; Colombo B; Curnis F; Girlanda S; Ponzoni M; Bertilaccio MT; Calcinotto A; Sacchi A; Ferrero E; Ferrarini M; Chesi M; Bergsagel PL; Bellone M; Tonon G; Ciceri F; Marcatti M; Caligaris-Cappio F; Corti A
Cancer Res; 2016 Apr; 76(7):1781-91. PubMed ID: 26869462
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth.
Carrer A; Moimas S; Zacchigna S; Pattarini L; Zentilin L; Ruozi G; Mano M; Sinigaglia M; Maione F; Serini G; Giraudo E; Bussolino F; Giacca M
Cancer Res; 2012 Dec; 72(24):6371-81. PubMed ID: 23222303
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
[TBL] [Abstract][Full Text] [Related]
11. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.
Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NA; Swarbrick A; Mittal V; Mellick AS
Cancer Res; 2013 Jan; 73(1):341-52. PubMed ID: 22836757
[TBL] [Abstract][Full Text] [Related]
13. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
15. Double attack on tumors by targeting with guidance molecules.
Weick A; Augustin HG
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):721-2. PubMed ID: 21411751
[No Abstract] [Full Text] [Related]
16. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
[TBL] [Abstract][Full Text] [Related]
17. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
Son HN; Nam JO; Kim S; Kim IS
Biochim Biophys Acta; 2013 Oct; 1833(10):2378-88. PubMed ID: 23792174
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides.
Corti A; Anderluzzi G; Curnis F
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559048
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
20. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
